Drinkhrw’s 4th trial is finished and going through the review process. On top of this, there are currently 5 other human trials using our tablet technology under way at major research institutions. Take a look for more information-


Read our second published clinical study:
In the 2nd published trial on Powered by Drink HRW tablets, it was shown that acute supplementation of H2 reduced submaximal HR significantly from min 1-9 in a VO2 max stress test. The study was a randomized double blind placebo controlled crossover design at South Utah University. Participants pulled in the same oxygen while their HR was lowered, leading to potentially significant benefits in endurance and repeated bout athletes.

Click the link below for the full Study


Read our third published clinical study:

The 3rd published trial on Powered by Drink HRW tablets, has shown that Drinking 1 L per day of hydrogen-rich water (HRW) for 28 days reduced liver fat accumulation in non-alcoholic fatty liver disease NAFLD. Dual-echo MRI revealed that HRW significantly reduced liver fat accumulation in individual liver regions-of-interest at 28-day follow-up, as compared to placebo administration. Twelve overweight outpatients with NAFLD participated in this double-blind, placebo-controlled, crossover trial. The promising results of the study suggest that hydrogen-rich water (HRW) may be proposed as an additional treatment in reducing NAFLD. The study was registered at ClinicalTrials.gov (ID NCT03625362)

Click the link below for the full study